Suppr超能文献

失调的 circ_0004913、circ_0008160、circ_0000517 及其作为肝细胞癌疾病监测和预后生物标志物的潜力。

Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.

机构信息

Department of Digestive Medical, Affiliated Nanhua Hospital, University of South China, Hengyang, China.

Department of Emergency, Affiliated Nanhua Hospital, University of South China, Hengyang, China.

出版信息

J Clin Lab Anal. 2021 Jun;35(6):e23785. doi: 10.1002/jcla.23785. Epub 2021 May 21.

Abstract

OBJECTIVE

Circular RNA_0004913 (circ_0004913), circular RNA_0008160 (circ_0008160), and circular RNA_0000517 (circ_0000517) are shown to be dysregulated in HCC tissues and cell lines, and also show potential in regulating hepatocellular carcinoma (HCC) pathogenesis. This current study attempted to find possible associations of circ_0004913, circ_0008160, and circ_0000517 with clinical features and prognosis of HCC patients.

METHODS

A hundred and fifty HCC patients who received hepatectomy were retrospectively reviewed, and their resected specimens including tumor tissues and paired adjacent tissues were obtained, in which the circ_0004913, circ_0008160, and circ_0000517 expressions were detected. Overall survival (OS) data were collected according to the clinical visit records.

RESULTS

Circ_0004913 (p < 0.001) and circ_0008160 (p < 0.001) were downregulated, while circ_0000517 (p < 0.001) was upregulated in tumor tissue compared with paired adjacent tissue. Additionally, tumor circ_0004913 was negatively associated with largest tumor size (p = 0.009) and Barcelona clinic liver cancer (BCLC) stage (p = 0.020), while tumor circ_0008160 and circ_0000517 were not correlated with any clinicopathological features of HCC patients (all p > 0.05). Tumor circ_0004913 high expression was associated with prolonged OS in total HCC patients (p = 0.008) and in subgroup of patients with largest tumor size <5 cm (p = 0.008). Tumor circ_0008160 high expression was correlated with longer OS in patients with BCLC stage B (p = 0.026). Univariate Cox's analysis disclosed that tumor circ_0004913 high expression was correlated with longer OS; while after adjustment by multivariate Cox's analysis, it failed to predict OS independently.

CONCLUSION

Circ_0004913 was downregulated in tumor tissue and may serve as a biomarker for evaluating disease severity and prognosis in HCC patients.

摘要

目的

Circ_0004913(circ_0004913)、Circ_0008160(circ_0008160)和 Circ_0000517(circ_0000517)在 HCC 组织和细胞系中表达失调,并且具有调节肝细胞癌(HCC)发病机制的潜力。本研究试图寻找 circ_0004913、circ_0008160 和 circ_0000517 与 HCC 患者临床特征和预后的可能关联。

方法

回顾性分析 150 例接受肝切除术的 HCC 患者,获取其切除标本,包括肿瘤组织和配对的相邻组织,检测 circ_0004913、circ_0008160 和 circ_0000517 的表达。根据临床随访记录收集总生存期(OS)数据。

结果

与配对的相邻组织相比,肿瘤组织中 circ_0004913(p<0.001)和 circ_0008160(p<0.001)下调,而 circ_0000517(p<0.001)上调。此外,肿瘤 circ_0004913 与最大肿瘤大小(p=0.009)和巴塞罗那临床肝癌(BCLC)分期(p=0.020)呈负相关,而肿瘤 circ_0008160 和 circ_0000517 与 HCC 患者的任何临床病理特征均无相关性(均 p>0.05)。肿瘤 circ_0004913 高表达与总 HCC 患者的总生存期延长相关(p=0.008),与肿瘤最大直径<5cm 的亚组患者的总生存期延长相关(p=0.008)。肿瘤 circ_0008160 高表达与 BCLC 分期 B 的患者的 OS 延长相关(p=0.026)。单因素 Cox 分析表明,肿瘤 circ_0004913 高表达与 OS 延长相关;而多因素 Cox 分析调整后,其不能独立预测 OS。

结论

肿瘤组织中 circ_0004913 下调,可能作为评估 HCC 患者疾病严重程度和预后的生物标志物。

相似文献

3
Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.
Cancer Med. 2019 Dec;8(17):7278-7287. doi: 10.1002/cam4.2584. Epub 2019 Oct 8.
5
Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
World J Gastroenterol. 2019 Apr 28;25(16):1964-1974. doi: 10.3748/wjg.v25.i16.1964.
6
Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma.
Sci Rep. 2021 Jul 22;11(1):14930. doi: 10.1038/s41598-021-94074-y.
8
Global microarray profiling identified as a potential immune-associated prognosis biomarker for hepatocellular carcinoma.
J Med Genet. 2019 Jan;56(1):32-38. doi: 10.1136/jmedgenet-2018-105440. Epub 2018 Aug 17.
9
[Circular RNA hsa_circ_0006834 is a potential prognostic biomarker for hepatocellular carcinoma].
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Nov 20;43(11):1850-1856. doi: 10.12122/j.issn.1673-4254.2023.11.03.

引用本文的文献

2
Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications.
Onco Targets Ther. 2024 Jan 22;17:7-26. doi: 10.2147/OTT.S437536. eCollection 2024.
3
Review of novel functions and implications of circular RNAs in hepatocellular carcinoma.
Front Oncol. 2023 Feb 20;13:1093063. doi: 10.3389/fonc.2023.1093063. eCollection 2023.
4
Circular RNAs in hepatocellular carcinoma: Recent advances.
World J Gastrointest Oncol. 2022 Jun 15;14(6):1067-1085. doi: 10.4251/wjgo.v14.i6.1067.
6
Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2.
J Clin Lab Anal. 2021 Dec;35(12):e23991. doi: 10.1002/jcla.23991. Epub 2021 Oct 19.

本文引用的文献

1
Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate in Hepatocellular Carcinoma.
Cancer Biother Radiopharm. 2023 Dec;38(10):708-719. doi: 10.1089/cbr.2020.3779. Epub 2020 Oct 6.
2
Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis.
Cancer Cell Int. 2020 Aug 25;20:404. doi: 10.1186/s12935-020-01496-1. eCollection 2020.
3
Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p.
Cancer Manag Res. 2020 May 14;12:3457-3468. doi: 10.2147/CMAR.S244024. eCollection 2020.
8
Emerging roles of circRNA in formation and progression of cancer.
J Cancer. 2019 Aug 28;10(21):5015-5021. doi: 10.7150/jca.30828. eCollection 2019.
10
Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Cell Physiol Biochem. 2018;51(1):290-300. doi: 10.1159/000495230. Epub 2018 Nov 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验